Search PubMed⌕ Search

PubMed · 8479299

Exercise and multiple sclerosis.

Abstract

Multiple sclerosis (MS) is a neurological disease characterized by a variety of potentially debilitating symptoms. The manner in which the disease affects each individual is unique; however, many individuals with MS have a normal life expectancy and remain ambulatory throughout their lives. Very little research has focused on understanding how MS affects basic physiologic responses during exercise. Four general topics have been addressed: autonomic control of heart rate (HR) and arterial blood pressure (BP), cardiorespiratory fitness, skeletal muscle function, and symptom instability under thermal stress. Abnormalities in cardiovascular reflexes have been observed in some MS individuals during quiescent testing; however, HR and BP responses during exercise have not confirmed such findings. Deficits in cardio-respiratory fitness appear to be present in moderately impaired individuals, which are not always present in minimally impaired persons. Similarly, abnormalities in skeletal muscle function have been reported in some individuals with MS, while absent in others. Training appears to improve both cardiorespiratory fitness and skeletal muscle function. Findings appear to be indirectly influenced by the level of physical impairment of the experimental sample. This factor needs to be considered in sample selection, as well as in analyzing and reporting data. Elicitation of symptoms in response to thermal stressors has been documented by several investigators using unreliable techniques to measure core temperature. The use of more valid methods during rest and exercise have not confirmed the relationship between symptoms and core temperature changes. It may be that thermal sensitivity, although typically reported by most MS individuals, is a symptom that is very unique to each individual and sample selection may have indirectly contaminated results in past research. Considerations for future research are discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J A Ponichtera-Mulcare. 1993. Exercise and multiple sclerosis.. https://pubmed.ncbi.nlm.nih.gov/8479299/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The diagnostic workup of patients with neuropathic pain.

Determining the causes of neuropathic pain is more than an epistemological exercise. At its essence, it is a quest to delineate mechanisms of dysfunction through which treatment strategies can be created that are effective in reducing, ameliorating, or eliminating symptomatology. To date, predictors of which patients will develop neuropathic pain or who will respond to specific therapies are lacking, and present therapies have been developed mainly through trial and error. Our current inability to make therapeutically meaningful decisions based on ancillary test data is illustrated by the following: In a study specifically designed to assess the response of patients with painful distal sensory neuropathies to the 5% lidocaine patch, no relationship between treatment response and distal leg skin biopsy, QST, or sensory nerve conduction study results could be established. From a mechanistic perspective, the hypothesis that the lidocaine patch would be most effective in patients with relatively intact epidermal innervation, whose neuropathic pain is presumed attributable to "irritable nociceptors," and least effective in patients with few surviving epidermal nociceptors, presumably with "deafferentation pain," was unproven. The possible explanations are multiple and outside the scope of this review. However, these findings, coupled with the disparity in C-fiber subtype involvement in diabetic small-fiber neuropathy, and the recently reported inability of enzyme replacement therapy in Fabry disease to influence intraepidermal innervation density, while having mixed effects on cold and warm QST thresholds, and beneficial effects on sudomotor findings, when therapeutic benefit was demonstrated, lead one to conclude that the specificity of ancillary testing in neuropathic pain is inadequate at present, and reinforce the aforementioned caveats about inferential conclusions from indirect data. The diagnosis of neuropathic pain mechanisms is in its nascent stages and ancillary testing remains "subordinate," "subsidiary," and "auxiliary" as defined in Webster's Third New International Dictionary. As a consequence of these difficulties, the recent approach by Bennett and his colleagues may have merit. They have hypothesized (and provide data in support) that chronic pain can be more or less neuropathic on a spectrum between "likely," "possible," and "unlikely," based on patient responses on validated neuropathic pain symptom scales, when compared with specialist pain physician certainty of the presence of neuropathic pain on a 100-mm visual analog scale. The symptoms most associated with neuropathic pain were dysesthesias, evoked pain, paroxysmal pain, thermal pain, autonomic complaints, and descriptions of the pain as being sharp, hot, or cold, with high sensitivity. Higher scores for these symptoms correlated with greater clinician certainty of the presence of neuropathic pain mechanisms. Considering each individual patient's chronic pain as being somewhere on a continuum between "purely nociceptive" and "purely neuropathic" may have diagnostic and therapeutic relevance by enhancing specificity, but this requires clinical confirmation. Thus, symptom assessment remains indispensable in the evaluation of neuropathic pain, ancillary testing notwithstanding

Autonomic Nervous System↗